SUV39H2 and breast carcinoma: We showed that SUV39H2 was abundantly overexpressed in breast cancer cell lines using quantitative real-time PCR and western blot analysis, and siRNA-mediated SUV39H2 knockdown significantly decreased cancer cell viability in vitro.